267 related articles for article (PubMed ID: 27027823)
1. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
Jia LH; Liu YN
Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-125b as a biomarker of Alzheimer's disease.
Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
5. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
6. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-221 serves as a biomarker for Parkinson's disease.
Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
[TBL] [Abstract][Full Text] [Related]
8. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease.
Wang J; Chen C; Zhang Y
J Clin Lab Anal; 2020 Jan; 34(1):e23006. PubMed ID: 31420923
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
Cao F; Liu Z; Sun G
Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
[TBL] [Abstract][Full Text] [Related]
10. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
[TBL] [Abstract][Full Text] [Related]
12. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
[TBL] [Abstract][Full Text] [Related]
13. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
Geekiyanage H; Jicha GA; Nelson PT; Chan C
Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
15. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
16. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
17. Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease.
Fransquet PD; Ryan J
Clin Biochem; 2018 Aug; 58():5-14. PubMed ID: 29885309
[TBL] [Abstract][Full Text] [Related]
18. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
Liu Q; Lei C
Exp Gerontol; 2021 Feb; 144():111187. PubMed ID: 33279668
[TBL] [Abstract][Full Text] [Related]
20. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
